The results that single clones of both SUIT-2 and MIA PaCa-2 showed lower proliferation rates and fewer colony formation counts compared to controls, indicated that the inactivation of PCSK6 could inhibit the growth of tumor cells in pancreatic cancer. Here, PCSK6 is linked to familial pancreatic carcinoma.